Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Plainview whey recalls continue

This article was originally published in The Tan Sheet

Executive Summary

Additional firms recall whey protein supplements potentially contaminated with salmonella from Plainview Milk Products Cooperative, including certain batches of SNI Pro Whey from Nutrition Global and Weigh Down Chocolate Flavor Nutrition Drink Mix from Lewis Laboratories International. A spokeswoman for GNC said in an e-mail the retailer's private label whey products are unaffected, but firms recalled four third-party stock-keeping units carried in the stores. Despite the range of firms and products affected by the recalls, Plainview acted quickly and no illnesses are reported linked to its ingredients (1"The Tan Sheet" July 13, 2009)

You may also be interested in...



Whey Recall Grows, But Plainview Approach May Prevent A Peanut Replay

The recall of whey protein ingredients rippling its way through the dietary supplement industry shows that companies must take a risk-based approach to product safety and cannot rely on good manufacturing practices alone to protect them

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Partisan Politics Returns To US FDA Congressional Oversight

The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel